This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other specified types of T/NK-cell lymphoma, hilmo, excluding all cancers
CD2_OTHER_SPECIAL_TNK_LYMPHOMA_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Other specified types of T/NK-cell lymphoma, hilmo, excluding all cancers
based on the number of shared cases.
Similar with more cases:
- Other specified types of T/NK-cell lymphoma, hilmo
- Mature T/NK-cell lymphomas, hilmo, excluding all cancers
- Mature T/NK-cell lymphomas, hilmo
- Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)
- Primary_lymphoid and hematopoietic malignant neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5 | - | - |
| Unadjusted period prevalence (%) | 0.00 | - | - |
| Median age at first event (years) | 69.98 | - | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
5
13
+∞
2.61
13.4
5.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
0
25
0.00
1.25
0.0
2.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
0
22
0.00
1.12
0.0
3.7
—
1.7
—
0
13
(3009508) Creatinine [Moles/volume] in Urine
0
21
0.00
0.84
0.0
2.9
—
9.8
—
0
16
(3012516) Albumin [Mass/volume] in Urine
0
19
0.00
0.82
0.0
3.1
—
17.1
—
0
11
(3011397) Hemoglobin [Presence] in Urine by Test strip
0
16
0.00
0.51
0.0
4.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
0
14
0.00
0.50
0.0
4.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
5
39
+∞
0.24
29.6
11.6
ml/min/173m2
76.2
77.7
—
5
29
(3045414) Leukocytes [Presence] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
0
5
0.00
0.00
0.0
4.8
—
132.4
—
0
5
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.0
—
4.7
—
0
5
(3013139) Helicobacter pylori Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
10.0
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
0
5
0.00
0.00
0.0
4.8
—
10.5
—
0
5
(3020564) Creatinine [Moles/volume] in Serum or Plasma
5
44
+∞
0.00
50.2
14.7
umol/l
76.6
72.4
—
5
44
(3016502) Oxygen saturation in Arterial blood
0
6
0.00
0.00
0.0
4.3
—
95.3
—
0
6
(40761535) Cells panel - Urine sediment
0
7
0.00
0.00
0.0
5.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
5
42
+∞
0.00
25.0
12.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
0
5
0.00
0.00
0.0
4.8
—
5.4
—
0
5
(3002256) Pathology report gross observation
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
5
45
+∞
-0.00
54.0
11.1
mg/l
27.0
26.5
—
5
34
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: CD2_OTHER_SPECIAL_TNK_LYMPHOMA_EXALLC – Other specified types of T/NK-cell lymphoma, hilmo, excluding all cancers
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).